Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulatedtumor marker in esophageal squamous cell carcinomas

GuimarÆes, Denise P; Oliveira, Ivanir M; Moraes, Emanuela de; Paiva, Geisilene R; Souza, Daniel M; Barnas, Christoph; Olmedo, Daniele B; Pinto, Carlos E; Faria, Paulo A; Gallo, Claudia Vitoria de Moura; Small, Isabele A; Ferreira, Carlos Gil Moreira; Hainaut, Pierre.
International Journal of Cancer ; 124(2): 272-279, 15 jan. 2009. ilus, tab
Artículo en Inglés | TXTC | ID: txt-23705

Documentos relacionados

  1. Missed opportunities to screen for Barrett's esophagus in the primary care setting of a large health system.
  2. Is metformin use associated with a reduced risk of oesophageal cancer? A systematic review and meta-analysis.
  3. Esophageal cancer in China: Practice and research in the new era.
  4. Endoscopic Treatment of Early-Stage Esophageal Cancer.
  5. Quality of Online Information for Esophageal Cancer.
  6. [Current status and challenges of prevention and control of esophageal cancer in China].
  7. [Modern Multimodal Concepts for Advanced and Metastatic Esophageal Cancer].
  8. Climate Change and the Esophagus: Speculations on Changing Disease Patterns as the World Warms.
  9. [Prevention of gastrointestinal cancer].
  10. [China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)].